Home/Filings/4/0000899243-19-019391
4//SEC Filing

Balak Salesh 4

Accession 0000899243-19-019391

CIK 0001279695other

Filed

Jul 8, 8:00 PM ET

Accepted

Jul 9, 5:54 PM ET

Size

16.2 KB

Accession

0000899243-19-019391

Insider Transaction Report

Form 4
Period: 2019-05-29
Balak Salesh
Chief Financial Officier
Transactions
  • Exercise/Conversion

    Common Stock

    2019-05-29+73,334201,558 total
  • Exercise/Conversion

    Stock Option (Right to Buy)

    2019-05-2973,3340 total
    Exercise: $0.00Exp: 2019-06-28Common Stock (73,334 underlying)
Holdings
  • Stock Option (Right to Buy)

    Exercise: $0.50Exp: 2023-04-20Common Stock (721,000 underlying)
    721,000
  • Stock Option (Right to Buy)

    Exercise: $0.00Exp: 2022-01-29Common Stock (40,000 underlying)
    40,000
  • Stock Option (Right to Buy)

    Exercise: $1.72Exp: 2019-11-09Common Stock (100,000 underlying)
    100,000
  • Stock Option (Right to Buy)

    Exercise: $0.50Exp: 2024-02-27Common Stock (216,300 underlying)
    216,300
  • Stock Option (Right to Buy)

    Exercise: $0.00Exp: 2019-11-12Common Stock (25,000 underlying)
    25,000
  • Stock Option (Right to Buy)

    Exercise: $0.00Exp: 2020-12-11Common Stock (40,000 underlying)
    40,000
Footnotes (9)
  • [F1]The price reported is stated in Australian dollars.
  • [F2]13,333 stock options vested and became exercisable on 12/31/2015, 13,333 stock options vested and became exercisable on 12/31/2016, and 13,334 stock options vest and become exercisable on 12/31/2017.
  • [F3]13,333 stock options vested and became exercisable on 12/31/2014, 13,333 stock options vested and became exercisable on 12/31/2015, and 13,334 stock options vested and became exercisable on 12/31/2016.
  • [F4]8,333 stock options vested and became exercisable on 12/31/2013, 8,333 stock options vested and became exercisable on 12/31/2014, and 8,334 stock options vested and became exercisable on 12/31/2015.
  • [F5]1/3 of the stock options vested and became exercisable on 12/31/2010, 1/3 of the stock options vested and became exercisable on 12/31/2011 and the remaining stock options vested and became exercisable on 12/31/2012.
  • [F6]10,000 stock options vested and became exercisable on 12/31/2010 and were exercised on 11/10/2011. 21,666 stock options vested and became exercisable on 12/31/11 and were exercised on 08/27/2012, 35,000 stock options vested and became exercisable on 12/31/2012, 25,000 stock options vested and became exercisable on 12/31/2013, and 13,334 stock options vested and became exercisable on 12/31/2014. The remaining options were all exercised on 05/29/2019.
  • [F7]206,000 of the stock options vested and became exercisable on 10/05/2016, 412,000 of the stock options vested and became exercisable on 12/31/2016 and 103,000 of the stock options vested and became exercisable on 02/23/2017.
  • [F8]216,300 stock options vested and became exercisable on December 31, 2017.
  • [F9]Includes (i) 194,362 shares in the form of CDIs Mr. Balak holds directly and (ii) 7,196 restricted fully paid shares.

Issuer

UNIVERSAL BIOSENSORS INC

CIK 0001279695

Entity typeother

Related Parties

1
  • filerCIK 0001397500

Filing Metadata

Form type
4
Filed
Jul 8, 8:00 PM ET
Accepted
Jul 9, 5:54 PM ET
Size
16.2 KB